LeMaitre Vascular, Inc.
LMAT
$92.34
-$4.25-4.40%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 256.28M | 249.60M | 240.87M | 234.64M | 226.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 256.28M | 249.60M | 240.87M | 234.64M | 226.26M |
| Cost of Revenue | 73.47M | 73.76M | 72.63M | 72.48M | 70.60M |
| Gross Profit | 182.82M | 175.84M | 168.24M | 162.16M | 155.66M |
| SG&A Expenses | 100.15M | 98.29M | 96.58M | 92.48M | 87.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 188.02M | 186.49M | 183.73M | 179.87M | 173.25M |
| Operating Income | 68.26M | 63.11M | 57.13M | 54.77M | 53.01M |
| Income Before Tax | 80.62M | 75.18M | 68.91M | 60.88M | 58.32M |
| Income Tax Expenses | 18.21M | 17.45M | 15.57M | 13.77M | 13.16M |
| Earnings from Continuing Operations | 62.40 | 57.73 | 53.34 | 47.12 | 45.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 62.40M | 57.73M | 53.34M | 47.12M | 45.16M |
| EBIT | 68.26M | 63.11M | 57.13M | 54.77M | 53.01M |
| EBITDA | 78.75M | 73.53M | 67.36M | 64.81M | 62.79M |
| EPS Basic | 2.75 | 2.55 | 2.36 | 2.09 | 2.01 |
| Normalized Basic EPS | 2.10 | 1.96 | 1.77 | 1.69 | 1.62 |
| EPS Diluted | 2.71 | 2.51 | 2.31 | 2.05 | 1.97 |
| Normalized Diluted EPS | 2.05 | 1.90 | 1.72 | 1.66 | 1.60 |
| Average Basic Shares Outstanding | 90.78M | 90.55M | 90.35M | 90.17M | 90.01M |
| Average Diluted Shares Outstanding | 93.28M | 93.15M | 93.09M | 91.53M | 91.36M |
| Dividend Per Share | 0.85 | 0.80 | 0.76 | 0.72 | 0.68 |
| Payout Ratio | 30.93% | 31.37% | 32.20% | 34.45% | 33.89% |